Floatz logo

Dynastat

Perioperative Care

National Taiwan University HospitalPhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Perioperative Care cohort.

Asset / SponsorPhaseRating
SIMVASTATIN
University of Auckland, New Zealand
Phase 3BB
Amantadine
Rabin Medical Center
Phase 2CCC
TESTOSTERONE UNDECYLATE
London North West Healthcare NHS Trust
D

Same molecule, other indications

Dynastat is also rated in:

Chronic Post-operative PainDormant
BB
Indicative ·
69 / 100
View asset →
sickle cell diseaseDormant
B
Indicative ·
60 / 100
View asset →
complex regional pain syndrome type 2Dormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →